Download PDF
Thromb Haemost 1967; 18(01/02): 101-113
DOI: 10.1055/s-0038-1655021
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Some Aspects of Fibrin Clot Lysis and Its Inhibition by Human Serum

M. J Gallimoke
1   Department of Biochemical Pharmacology, Therapeutics Research Division, Pfizer Ltd., Sandwich, Kent (England)
,
J. T. B Shaw
1   Department of Biochemical Pharmacology, Therapeutics Research Division, Pfizer Ltd., Sandwich, Kent (England)
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

The lysis by plasmin of fibrin clots prepared from plasminogen-deficient fibrinogen, and by urokinase of similar clots prepared from plasminogen-rich fibrinogen has been studied. In a simple system containing no plasminogen the clot lysis time is inversely proportional to the concentration of added plasmin, and zero order kinetics are obeyed. The reciprocal of the lysis time is a measure of the fibrinolytic activity in the system, and may be used to study antiplasmins. When serum was included a reduction in reciprocal lysis time resulted, the extent of which varied linearly with the amount of serum added. These relationships persisted whether soluble or insoluble plasmin preparations were used and whether or not chloride ions were present. They indicate that serum antiplasmins behave as irreversible or pseudo-irreversible inhibitors. It was found that sodium chloride exerts a potentiating effect on fibrinolysis by plasmin, but does not influence the extent to which the enzyme is inhibited by serum antiplasmins.

When fibrin clots were prepared from plasminogen-rich fibrinogen, and urokinase was included, a direct relationship was found to exist between the concentration of urokinase and the square of the reciprocal clot lysis time. When serum was added, vigorous inhibition of fibrinolysis resulted when sodium chloride was present; no inhibition was observed in its absence. It is proposed that sodium chloride weakens the interaction between plasminogen and fibrin in the clots, and renders the plasmin produced by the action of urokinase more susceptible to inhibition by antiplasmins. Evidence in support of this hypothesis is presented and the kinetics of fibrinolysis by plasmin, and its inhibition, are discussed.

 

  • References

  • 1 Berg W, Korsan-Bengtsen K, Ygge J. Plasminogen assay by means of the lysis time method. Thrombos. Diathes. haemorrh. (Stuttg) 14: 127 1965;
    PubMedSearch in Google Scholar
  • 2 Bergstrom K, Wallen P. Removal of contaminating plasminogen from purified bovine fibrinogen. Arkivför Kemi. 17: 503 1961;
    PubMedSearch in Google Scholar
  • 3 Derechin M. The assay of human plasminogen with casein as substrate. Biochem. J. 78: 443 1961;
    CrossrefPubMedSearch in Google Scholar
  • 4 Gallimore M. J, Nulkar M. V, Shaw J. T. B. A comparative study of the inhibitors of fibrinolysis in human, dog and rabbit blood. Thrombos. Diathes. haemorrh. (Stuttg) 14: 145 1965;
    PubMedSearch in Google Scholar
  • 5 Kline D. L, Fishman J. B. Improved procedure for the isolation of human plasminogen. J. biol. Chem. 236: 3232 1961;
    PubMedSearch in Google Scholar
  • 6 Kline D. L, Fishman J. B. Preparation, stabilisation and some properties of purified human plasmin. Thrombos. Diathes. haemorrh. (Stuttg) 11: 15 1964;
    PubMedSearch in Google Scholar
  • 7 Maxwell R. E, Lewandowski V, Nickel V. S. Effects of some aminoacids on the inhibition of plasmin by antiplasmin. Biochim. biophys. Acta (Amst) 99: 342 1965;
    CrossrefPubMedSearch in Google Scholar
  • 8 Mosesson M. W. The preparation of human fibrinogen free of plasminogen. Biochim. biophys. Acta (Amst) 57: 204 1962;
    CrossrefPubMedSearch in Google Scholar
  • 9 Nanninga L. B, Guest M. M. On the interaction of fibrinolysin (plasmin) with the inhibitors antifibrinolysin and soybean trypsin inhibitor. Arch. Biochem. 108: 542 1964;
    CrossrefPubMedSearch in Google Scholar
  • 10 Nanninga L. B, Guest M. M. Rapid determination of antifibrinolysin (antiplasmin) in plasma. Thrombos. Diathes. haemorrh. (Stuttg) 15: 273 1966;
    PubMedSearch in Google Scholar
  • 11 Robbins K. C, Summaria L. Purification of human plasminogen and plasmin by gel filtration on Sephadex and chromatography on Diethylaminoethyl-Sephadex. J. biol. Chem. 238: 952 1963;
    PubMedSearch in Google Scholar
  • 12 Robbins K. C, Summaria L, Elwyn D, Barlow G. H. Further studies on the purification and characterization of human plasminogen and plasmin. J. biol. Chem. 240: 541 1965;
    PubMedSearch in Google Scholar
  • 13 Roberts P. S, Burkat R. K. The stabilising effect of neutral salts on plasmin. Biochim. biophys. Acta (Amst) 113: 193 1966;
    CrossrefPubMedSearch in Google Scholar
  • 14 Scheraga H. A, Laskowski M. The fibrinogen-fibrin conversion. Advanc. Protein Chem. 12: 1 1957;
    PubMedSearch in Google Scholar
  • 15 Sherry S, Alkjaersig N. Studies on the fibrinolytic enzyme of human plasma. Thrombos. Diathes. haemorrh. (Stuttg) 01: 264 1957;
    PubMedSearch in Google Scholar
  • 16 Sherry S, Lindemeyer R. I, Fletcher A. P, Alkjaersig N. Studies on enhanced fibrinolytic activity in man. J. clin. Invest. 38: 810 1959;
    CrossrefPubMedSearch in Google Scholar
  • 17 Taylor F. B, Allen L. W, Bickford A. F. Fractionation and characterization of an inhibitor of plasmin found in normal plasma. Arch. Biochem. 104: 277 1964;
    CrossrefPubMedSearch in Google Scholar
  • 18 Webb J. L. Enzyme and metabolic inhibitors. Vol. 1, Chapter 5. Academic Press; New York and London: 1963
    Search in Google Scholar